【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 12
2 Introduction 13
2.1 Vision Care Overview 13
3 Products under Development 15
3.1 Vision Care – Pipeline Products by Stage of Development 15
3.2 Vision Care – Pipeline Products by Segment 16
3.3 Vision Care – Pipeline Products by Territory 17
3.4 Vision Care – Pipeline Products by Regulatory Path 18
3.5 Vision Care – Pipeline Products by Estimated Approval Date 19
3.6 Vision Care – Ongoing Clinical Trials 20
4 Vision Care – Pipeline Products under Development by Companies 21
4.1 Vision Care Companies – Pipeline Products by Stage of Development 21
4.2 Vision Care – Pipeline Products by Stage of Development 24
5 Vision Care Companies and Product Overview 27
5.1 Adventus Technology Inc Company Overview 27
5.1.1 Adventus Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 27
5.2 Alcon, Inc. Company Overview 28
5.2.1 Alcon, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28
5.3 Apeliotus Ophthalmics Company Overview 32
5.3.1 Apeliotus Ophthalmics Pipeline Products & Ongoing Clinical Trials Overview 32
5.4 Auburn University Company Overview 34
5.4.1 Auburn University Pipeline Products & Ongoing Clinical Trials Overview 34
5.5 Axcelon Biopolymers Corp. Company Overview 35
5.5.1 Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview 35
5.6 Bar-Ilan University Company Overview 36
5.6.1 Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview 36
5.7 Bausch & Lomb Incorporated Company Overview 38
5.7.1 Bausch & Lomb Incorporated Pipeline Products & Ongoing Clinical Trials Overview 38
5.8 Belfanti – Fureder – Meidl technisches Buro f Elektro u Haustechnik GmbH Company Overview 42
5.8.1 Belfanti – Fureder – Meidl technisches Buro f Elektro u Haustechnik GmbH Pipeline Products & Ongoing Clinical Trials Overview 42
5.9 Bionic Vision Australia Company Overview 43
5.9.1 Bionic Vision Australia Pipeline Products & Ongoing Clinical Trials Overview 43
5.10 Body Organ Biomedical Corp. Company Overview 48
5.10.1 Body Organ Biomedical Corp. Pipeline Products & Ongoing Clinical Trials Overview 48
5.11 Children’s Hospital Boston Company Overview 50
5.11.1 Children’s Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 50
5.12 Consejo Superior de Investigaciones Cientificas Company Overview 51
5.12.1 Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview 51
5.13 CooperVision, Inc. Company Overview 53
5.13.1 CooperVision, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
5.14 Cornell University Company Overview 54
5.14.1 Cornell University Pipeline Products & Ongoing Clinical Trials Overview 54
5.15 EP Global Communications, Inc. Company Overview 55
5.15.1 EP Global Communications, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
5.16 eSight Corporation Company Overview 56
5.16.1 eSight Corporation Pipeline Products & Ongoing Clinical Trials Overview 56
5.17 Euclid Systems Corporation Company Overview 57
5.17.1 Euclid Systems Corporation Pipeline Products & Ongoing Clinical Trials Overview 57
5.18 Eyegenix Company Overview 58
5.18.1 Eyegenix Pipeline Products & Ongoing Clinical Trials Overview 58
5.19 EyeNetra, Inc. Company Overview 59
5.19.1 EyeNetra, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
5.20 Eyenovations Company Overview 60
5.20.1 Eyenovations Pipeline Products & Ongoing Clinical Trials Overview 60
5.21 EyeYon Medical Company Overview 61
5.21.1 EyeYon Medical Pipeline Products & Ongoing Clinical Trials Overview 61
5.22 Imperial College London Company Overview 65
5.22.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 65
5.23 iSTAR Medical Company Overview 66
5.23.1 iSTAR Medical Pipeline Products & Ongoing Clinical Trials Overview 66
5.24 Johnson & Johnson Vision Care, Inc. Company Overview 67
5.24.1 Johnson & Johnson Vision Care, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
5.25 Massachusetts Eye and Ear Infirmary Company Overview 72
5.25.1 Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 72
5.26 Medisse BV Company Overview 73
5.26.1 Medisse BV Pipeline Products & Ongoing Clinical Trials Overview 73
5.27 Mercy Research and Development Company Overview 74
5.27.1 Mercy Research and Development Pipeline Products & Ongoing Clinical Trials Overview 74
5.28 Microbiosensor Ltd Company Overview 76
5.28.1 Microbiosensor Ltd Pipeline Products & Ongoing Clinical Trials Overview 76
5.29 Monash University Company Overview 77
5.29.1 Monash University Pipeline Products & Ongoing Clinical Trials Overview 77
5.30 Nano Retina, Inc. Company Overview 79
5.30.1 Nano Retina, Inc. Pipeline Products & Ongoing Clinical Trials Overview 79
5.31 Novartis AG Company Overview 80
5.31.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 80
5.32 Ocular Dynamics, LLC Company Overview 83
5.32.1 Ocular Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview 83
5.33 Ocutec Limited Company Overview 84
5.33.1 Ocutec Limited Pipeline Products & Ongoing Clinical Trials Overview 84
5.34 PixelOptics, Inc. Company Overview 85
5.34.1 PixelOptics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 85
5.35 Pixium Vision Company Overview 86
5.35.1 Pixium Vision Pipeline Products & Ongoing Clinical Trials Overview 86
5.36 Presbia Plc Company Overview 87
5.36.1 Presbia Plc Pipeline Products & Ongoing Clinical Trials Overview 87
5.37 Queensland University of Technology Company Overview 90
5.37.1 Queensland University of Technology Pipeline Products & Ongoing Clinical Trials Overview 90
5.38 ReVision Optics, Inc. Company Overview 91
5.38.1 ReVision Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 91
5.39 Stanford University Company Overview 95
5.39.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 95
5.40 Tel Aviv University Company Overview 96
5.40.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 96
5.41 The Hong Kong University of Science and Technology Company Overview 97
5.41.1 The Hong Kong University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 97
5.42 The Johns Hopkins University Company Overview 98
5.42.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 98
5.43 UltraVision CLPL Company Overview 100
5.43.1 UltraVision CLPL Pipeline Products & Ongoing Clinical Trials Overview 100
5.44 University of Auckland Company Overview 101
5.44.1 University of Auckland Pipeline Products & Ongoing Clinical Trials Overview 101
5.45 University of California, San Diego Company Overview 103
5.45.1 University of California, San Diego Pipeline Products & Ongoing Clinical Trials Overview 103
5.46 University of Florida Company Overview 105
5.46.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 105
5.47 University of Oxford Company Overview 106
5.47.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 106
5.48 University of Rochester Company Overview 108
5.48.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 108
5.49 University of Tennessee, Knoxville Company Overview 110
5.49.1 University of Tennessee, Knoxville Pipeline Products & Ongoing Clinical Trials Overview 110
5.50 University of Valencia Company Overview 112
5.50.1 University of Valencia Pipeline Products & Ongoing Clinical Trials Overview 112
5.51 University of Washington Company Overview 114
5.51.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 114
5.52 Visioneering Technologies, Inc. Company Overview 117
5.52.1 Visioneering Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 117
5.53 VISTAKON Pharmaceuticals, LLC Company Overview 123
5.53.1 VISTAKON Pharmaceuticals, LLC Pipeline Products & Ongoing Clinical Trials Overview 123
5.54 Visual Pathways, Inc. (Inactive) Company Overview 124
5.54.1 Visual Pathways, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 124
5.55 Visus Technology, Inc. Company Overview 126
5.55.1 Visus Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 126
5.56 Yolia Health Company Overview 127
5.56.1 Yolia Health Pipeline Products & Ongoing Clinical Trials Overview 127
5.57 Ziemer Ophthalmic Systems AG Company Overview 128
5.57.1 Ziemer Ophthalmic Systems AG Pipeline Products & Ongoing Clinical Trials Overview 128
5.58 ZircLight Inc. Company Overview 129
5.58.1 ZircLight Inc. Pipeline Products & Ongoing Clinical Trials Overview 129
6 Vision Care- Recent Developments 131
7 Appendix 210
7.1 Methodology 210
7.2 About GlobalData 212
7.3 Contact Us 213
7.4 Disclaimer 213
【レポート販売概要】
■ タイトル：世界のビジョンケア機器開発動向：医療機器パイプライン分析2015■ 英文：Vision Care - Medical Devices Pipeline Assessment, 2015
■ 発行日：2016年1月1日
■ 調査会社：GlobalData
■ 商品コード：GDME0135EPD
■ 調査対象地域：グローバル
- 二酸化チタンの世界市場動向及び予測2015The present report is an essential resource for a one looking for detailed information on the world titanium dioxide market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together give a true …
- 大腸癌治療薬の世界市場：治療、研究開発、市場予測Colorectal Cancer Drugs – Your New Guide to that Market, its R&D and Sales Potentials Do you want to assess the future of colorectal cancer medicines? Visiongain’s new report gives you revenue predictions for that industry from 2015, helping you stay ahead in knowledge and benefit your influence. Our study shows you results, R&D trends, opportunities, interviews and revenue forecasts. In that anal …
- 世界の鉛市場：市場規模、動向、メーカー動向Scope The report presents a thorough study of lead, covering both global and regional markets It aims to give a proper picture of the market, as well as its trends, perspectives and opportunities Comprehensive data showing lead production, consumption, trade statistics and prices are provided (both nationwide and worldwide) Each country’s market overview covers the following: lead production in th …
- 苛性ソーダ（水酸化ナトリウム）の世界市場2017-2021About Caustic Soda Caustic soda is industrially produced by membrane cell, diaphragm cell, and mercury cell processes. Among these, membrane electrolysis and diaphragm electrolysis processes are widely preferred. In both these processes, sodium chloride solution is electrolytically decomposed, which results in the synthesis of caustic soda and the liberation of hydrogen gas and chlorine gas. Techn …
- 世界の非ホジキンリンパ腫治療市場（2014-2018）About Non-Hodgkin Lymphoma (NHL) and its Diagnostic Procedures Non-Hodgkin lymphoma (NHL) is a condition of the human body leading to the production of abnormal lymphocytes. In normal circumstances, the lymphocytes grow and die. However, in NHL they do not die; instead they grow and further divide. NHL can begin either in the T-cells or B-cells, though mostly it begins in the B-cells. The location …
- 航空機用タイヤの世界市場2017-2021ABSTRACTAbout Aircraft Tire Tires are an integral component of aircraft and are produced using raw materials such as natural rubber, nylon tire cord fabric, and carbon black. Rubber chemicals and synthetic rubber are also widely used during the production of aircraft tires. The durability of aircraft tires depends on the aircraft models (endurance varies between 30-200 landings). However, with the …
- ワイヤレスビル管理サービスの世界市場2017-2021About Wireless Building Management ServicesWireless solutions are a set of networks, components, and services that are installed in building facilities to ensure a seamless and reliable indoor coverage. In wireless technology, electromagnetic waves are deployed to transmit information in the form of signal using a communication channel. Technavio’s analysts forecast the global wireless building ma …
- 韓国の病院用品市場（～2021）South Korea Hospital Supplies Market Outlook to 2021 - Disposable Hospital Supplies, Mobility Aids and Transportation Equipment, Operating Room Equipment, Patient Examination Devices, Sterilization Equipment and Syringes and Needles Summary GlobalData’s new report, "South Korea Hospital Supplies Market Outlook to 2021 - Disposable Hospital Supplies, Mobility Aids and Transportation Equipment, Oper …
- 肝細胞癌：世界の臨床試験レビュー（2014年上半期）Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2014" provides data on the Hepatocellular Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatocellular Carcinoma. It includes an overview of the trial num …
- 世界のタブレットPC用OS市場動向（2012-2016）TechNavio's analysts forecast the Global Tablet Operating System (OS) market to grow at a CAGR of 35.2 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing sale of tablets. The Global Tablet OS market has also been witnessing timely upgrades of OS. However, high production costs could pose a challenge to the growth of this market. TechNavio …
- 慣性航法装置（INS）の世界市場2016-2020About Inertial Navigation Systems An inertial navigation system (INS) helps in determining the position, orientation, and velocity of a moving object. It consists of an inertial measurement unit (IMU), such as an accelerometer (measures linear acceleration) and gyroscope (measures angular velocity), which tracks the position of the object. INS is widely used in commercial aviation (in aircraft), d …
- 前立腺生検の世界市場2017-2021：針生検、液体生検About Prostate Biopsy Market Biopsy is a clinical procedure primarily used in the detection and extraction of malignant or cancerous cells and their abnormal growth in the body for further analysis and interpretation of diseases. The purpose of removing tissues or cells during the procedure is mainly to limit the spread of tumor, minimize morbidity, and eliminate interference with future treatment …
- 内視鏡：現在および将来プレイヤーEndoscopy - Current and Future Players Summary The Endoscopy market in Europe is a dynamic market that is expected to grow through 2021. The market is also very saturated with intense competition due to the availability of similar product offerings across market players. In the face of increasing hospital consolidation into one network and the trend of oligopoly purchasing, i.e. purchasing more pr …
- 高級香水の世界市場：価格別（50〜100ドル、100〜200ドル、200ドル以上）、エンドユーザー別（男性、女性、ユニセックス）、流通経路別（専門店、オンラインストア）The luxury perfume market size was valued at $11.7 Bn in 2018 and is expected to reach $16.8 Bn by 2026, registering a CAGR of 5.3% from 2019 to 2026. Lifestyle consciousness and increased buying power of customers are major impacts of increased disposable income, which naturally leads to a growth in usage of products and services. Increase in employment rate is impels rapid growth of disposable i …
- バイオシミラー（バイオ後続品）のグローバル市場：主要地域における制度動向、パイプライン分析BIOSIMILARS - Regulatory Framework and Pipeline Analysis Summary Biosimilars are copied versions of biologics that offer a 20-50% reduction in cost compared with innovative biologic products. Biosimilars are getting the world wide attention as the cost of the innovative biologics are enormously high and even minimal reduction in price will reduce the healthcare spending substantially. All the coun …
